Amplyx to Participate in Upcoming Antifungal Webinar Presented by Maxim Group LLC
SAN DIEGO, Sept. 14, 2020 /PRNewswire/ -- Amplyx Pharmaceuticals, a clinical-stage biopharmaceutical company developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems, announced today that Ciara Kennedy, Ph.D, president and chief executive officer, has been invited to present at A Too Quiet Pandemic – Fungal Disease webinar, presented by Maxim Group LLC and M-Vest, on Thursday September 17th, 2020. Dr. Kennedy will participate in a panel discussion led by Dr. Jason McCarthy, Maxim's senior managing director of Biotechnology Equity Research, along with other important voices in the healthcare industry.
Panel Session Title: A Too Quiet Pandemic – Fungal Disease
About Amplyx Pharmaceuticals
View original content to download multimedia:http://www.prnewswire.com/news-releases/amplyx-to-participate-in-upcoming-antifungal-webinar-presented-by-maxim-group-llc-301128500.html
SOURCE Amplyx Pharmaceuticals